STAT

Beware of doomsday scenarios for health care spending

Medical progress can clearly be costly, but doomsday scenarios based on simple extrapolations of today's numbers are out of touch with reality.

Fair pricing activists applauded the news earlier this month that the FDA approved another drug to cure hepatitis C. That this new medicine is cheaper and treats people quicker than the existing hepatitis C drugs goes to show how fast healthy competition can change the outlook on health spending.

Not long ago, health economists were promoting a doomsday scenario that the new crop of hepatitis C drugs would break the bank. To be sure, these drugs were a huge advance, offering cures for hepatitis C rather than holding actions against this potentially disabling and even deadly liver disease. But , and the costs would be felt over short time frame rather than be spread out over

You're reading a preview, sign up to read more.

More from STAT

STAT3 min read
Amid Privacy Concerns, Startup Becomes First Consumer DNA Company To Offer Anonymous Sequencing
Nebula will offer anonymous testing amid public concerns about the privacy of genetic data and law enforcement use of public DNA databases to identify suspects.
STAT3 min readPolitics
Pelosi’s Drug Pricing Plan Would Let Medicare Negotiate Prices For Up To 250 Drugs
The new legislation is more aggressive than prior concepts that had circulated among lobbyists and congressional staff this year.
STAT5 min read
‘Please Know You’re Not Alone’: For Dementia Caregivers, A Place To Share With Strangers — And Be Honest
It was an indescribable relief to finally connect with someone who understood what, exactly, it was like.